Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Most cited article(s)

  • <sup>177</sup>Lu-PSMA-I&amp;T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
    You have access
    177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
    Amir Karimzadeh, Matthias Heck, Robert Tauber, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 402-409; DOI: https://doi.org/10.2967/jnumed.122.264402
  • CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
    You have access
    CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
    Michael D. Farwell, Raymond F. Gamache, Hasan Babazada, Matthew D. Hellmann, James J. Harding, Ron Korn, Alessandro Mascioni, William Le, Ian Wilson, Michael S. Gordon, Anna M. Wu, Gary A. Ulaner, Jedd D. Wolchok, Michael A. Postow and Neeta Pandit-Taskar
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 720-726; DOI: https://doi.org/10.2967/jnumed.121.262485
  • Open Access
    Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review
    Philipp T. Meyer, Sabine Hellwig, Ganna Blazhenets and Jonas A. Hosp
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 971-980; DOI: https://doi.org/10.2967/jnumed.121.263085
  • Correlation of <sup>68</sup>Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study
    Open Access
    Correlation of 68Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study
    Christine E. Mona, Matthias R. Benz, Firas Hikmat, Tristan R. Grogan, Katharina Lueckerath, Aria Razmaria, Rana Riahi, Roger Slavik, Mark D. Girgis, Giuseppe Carlucci, Kimberly A. Kelly, Samuel W. French, Johannes Czernin, David W. Dawson and Jeremie Calais
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 1021-1026; DOI: https://doi.org/10.2967/jnumed.121.262426
  • You have access
    Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
    George Sgouros, Yuni K. Dewaraja, Freddy Escorcia, Stephen A. Graves, Thomas A. Hope, Amir Iravani, Neeta Pandit-Taskar, Babak Saboury, Sara St. James and Pat B. Zanzonico
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 12S-22S; DOI: https://doi.org/10.2967/jnumed.121.262750
  • Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with <sup>177</sup>Lu-PSMA Therapy: A Multicenter Retrospective Analysis
    You have access
    Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with 177Lu-PSMA Therapy: A Multicenter Retrospective Analysis
    Masatoshi Hotta, Andrei Gafita, Johannes Czernin and Jeremie Calais
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1484-1488; DOI: https://doi.org/10.2967/jnumed.121.263441
  • You have access
    Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
    Jacek Capala, Stephen A. Graves, Aaron Scott, George Sgouros, Sara St. James, Pat Zanzonico and Brian E. Zimmerman
    Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 3S-11S; DOI: https://doi.org/10.2967/jnumed.121.262749
  • You have access
    To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy
    Sandy Srinivas and Andrei Iagaru
    Journal of Nuclear Medicine November 1, 2021, 62 (11) 1487-1488; DOI: https://doi.org/10.2967/jnumed.121.263035
  • Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
    You have access
    Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
    George A. Prenosil, Hasan Sari, Markus Fürstner, Ali Afshar-Oromieh, Kuangyu Shi, Axel Rominger and Michael Hentschel
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 476-484; DOI: https://doi.org/10.2967/jnumed.121.261972
  • Impact of <sup>18</sup>F-FET PET/MRI on Clinical Management of Brain Tumor Patients
    You have access
    Impact of 18F-FET PET/MRI on Clinical Management of Brain Tumor Patients
    Cornelia Brendle, Caroline Maier, Benjamin Bender, Jens Schittenhelm, Frank Paulsen, Mirjam Renovanz, Constantin Roder, Salvador Castaneda-Vega, Ghazaleh Tabatabai, Ulrike Ernemann and Christian la Fougère
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 522-527; DOI: https://doi.org/10.2967/jnumed.121.262051

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire